Exhibitor Profile | Yangzhou Matesjay Meters Co., Ltd. Joins RACC with Booth Number 1C-H08

Yangzhou Matesjay Meters Co., Ltd. will be joining RACC to exhibit their latest pressure gauges during the show(booth number: 1C-H08). 2020 China International Air-Conditioning, Ventilation, Refrigeration and Cold Chain Expo (RACC) is a professional exhibition with industry influence in China. RACC 2020 will rely on the advantages of Zhejiang Province as the global HVACR industrial base. Hope to meet you at the show.

Yangzhou Matesjay Meters Co., Ltd. (formerly “Yangzhou XIND Refrigeration Parts Co., Ltd.”), founded in August, 2007, is an export-oriented specialized production enterprise engaged in both trade and producing  with its own import and export right. Located in the scenic North Industrial Park of Jiangdu District, Yangzhou, to the east of Beijing-Shanghai Expressway, south of Ningqi Railway, and north of Yangzhou Taizhou International Airport, Matesjay has an advantageous geographical position with excellent transportation conditions.

Inside the factory

The company mainly produces and deals in common pressure gauges, oxygen/acetylene pressure gauges, medical pressure gauges, liquid-filling pressure gauges, chemical industrial pressure gauges, refrigerant pressure gauges, capsule pressure gauges and partial refrigeration parts. Our products have passed CMA & CE certification and have been sold to over twenty provinces, cities and autonomous regions in China and exported to South America, Middle East and Southeast Asia. With the operation principle of “superior quality, customers first; making progress, sincere service”, we have won trust and support from our customers on our exquisite craft and excellent quality!

Product display


Matesjay is in a period of rapid development. We look forward to joining hands with you in developing and creating the future together!


Certificates display

The global publicity of RACC has been fully opened. Besides online advertisement, the propaganda has gone through 17 stations including Febrava in Brazil and AHR in the United States, the publicity is ongoing.